bcbs glp 1 coverage change Blue Cross Blue Shield of Michigan won't cover popular weight-loss drugs Paving the way for expanded

Most denials are simple documentation hiccups, but there are a few situations where the IRS draws a hard line

In fact, tirzepatide might even help protect the kidneys in some cases

GLP-1 receptor agonists are not contraindicated with levothyroxine, but they may delay gastric emptying which could theoretically affect levothyroxine absorption

Retatrutide is an investigational drug that is not FDA-approved

Given the promising data from this study, Neurogastrx is looking to launch a larger Phase 2 study in 2025

Maintaining a healthy weight requires a healthy dietary pattern and regular exercise, along with attention to other aspects of your health and well-being, such as sleep, self-care, and social connection